Cure for Thyroid Cancer
OwnerBrian Haneyinventor
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods and a device for curing thyroid cancer. In embodiments, the invention provides mechanisms for curing thyroid cancer by replacing the cancerous thyroid with a synthetic biotechnology, utilizing both methods and an implantable device for direct drug delivery. The device, may be a cylindrical titanium tube, containing a hormone store at a specific triiodothyronine to thyroxine ratio, tailored to the individual patient's needs post-surgical removal of the cancerous thyroid.
Claims20
A method for curing thyroid cancer, the method comprising:
- signaling the delivery of thyroid hormone on a timed basis, wherein the time basis is on a twelve-hour interval,
- sending a command to a thyroid hormone pump,
- loading a portion of the thyroid hormone supply by the pump to a secretion chamber,
- pumping thyroid hormones from a secretion chamber to the human body by the thyroid hormone pump, and
- optimizing metabolic homeostasis in the human body.
A method for curing thyroid cancer, the method comprising:
- diagnosing a patient with thyroid cancer,
- customizing and engineering a synthetic thyroid to the specific thyroid hormone needs of the patient,
- removing the cancerous thyroid,
- replacing the cancerous thyroid with the customized and engineered synthetic thyroid,
- signaling, by the synthetic thyroid, the delivery of thyroid hormone on a timed basis, wherein the time basis is on a twelve-hour interval,
- sending a command to a thyroid hormone pump,
- loading a portion of the thyroid hormone supply by the pump to a secretion chamber,
- pumping thyroid hormones from a secretion chamber to the human body by the thyroid hormone pump, and
- optimizing thyroid hormone homeostasis in the patient's body.
A device for curing thyroid cancer, the device comprising:
- a cylindrical titanium tube, further comprising:
- a thyroid hormone store, the thyroid hormone store further comprising thyroid hormone at a ratio of parts one to thirteen, triiodothyronine to thyroxine,
- the cylindrical tube further comprising a pump, pumping the thyroid hormone at a ratio of parts one to thirteen, triiodothyronine to thyroxine,
- the cylindrical tube further being engineered and customized for the specific needs of a patient, having their cancerous biological thyroid completely removed, and
- the cylindrical tube further comprising a delivery device by which the thyroid hormone at a ratio of parts one to thirteen, triiodothyronine to thyroxine, is pumped into the body to optimize metabolic homeostasis.
Dependencies are inferred from the claim text.